A one-day Biocom | Lonza virtual symposium
Digitally delivered | Tuesday 15 September 2020
Biocom and Lonza Biologics are pleased to invite you to join us for a complimentary virtual symposium to gain insight from experts in the different approaches and techniques to successfully progress biotherapeutic candidates from discovery to the clinic. Hear about updates on enhancements to new and established technologies enabling translational research. The day includes talks from industry experts, local biotech companies and technical specialists from Lonza.
Our networking breaks and virtual lunch offers the opportunity to speak with fellow scientists, presenters and Lonza specialists. During the symposium, you will have the opportunity to book a 1-on-1 Virtual Drop-in-Clinic Session with our scientific experts to be held in the days following the symposia.
Attendance at this event is complimentary and by invitation.
For more information, including the latest agenda and to register, please visit:
Insight and discussion with experts
|08.00 am – 08.10 am||Welcome and opening remarks|
|08.10 am – 08.45 am||An industry perspective – What to consider when moving therapeutic proteins from development to first in human trials
Dr. Hari Kumar | Pharmaceutical Executive; Independent Board Member; former CEO Adheron Therapeutics
|08.45 am – 9:20 am||Early developability assessment tools – Successful de-risking strategies to support progression of biologics from discovery to development
Dr. Yvette Stallwood | Head of Applied Protein Services, Lonza
|9:20 am – 9.50 am||Kodiak Sciences, Inc.
Dr. Victor Perlroth | Chairman and Chief Executive Officer
|9.50 am – 10.10 am||Virtual coffee break | Q&A with speakers
|10.10 am – 10.45 am||Addressing challenges with complex proteins, including bispecifics, using Lonza’s GS Xceed® Toolbox
Dr. Peter O’Callaghan | Principle scientist R&D, Lonza
|10.45 am – 11.15 am||Gene to IND: CMC team governance
Dr. Ruby Casareno | Vice President Technical Operations, Allakos Inc.
|11.15 am – 11.50 am||Approaches to maximize successful development of cell lines expressing a diverse range of proteins
Dr. Alison Porter | Head of Expression System Sciences, Lonza
|11.50 am – 12.30 pm||Virtual Networking Lunch | Q&A with speakers|
|12.30 pm – 1.05 pm||Biologics drug product development: A holistic early stage development approach considering formulation, primary packaging and application
Dr. Susanne Joerg | Head of Pharmaceutical Development, Lonza
|1.05 pm – 1.35 pm||Annexon, Inc.
Dr. Cecilia Oliyai, PhD | Vice President, CMC and Supply Chain Logistics
|1.35 pm – 1.55 pm||Virtual coffee break | Q&A with speakers|
|1.55 pm – 2.55 pm||Biocom member company presentations
— Abhijit Bhatia | VP, Global Corporate & Business Development, Rakuten Medical
— Leslie Nangle | Sr. Director of Research, aTyr Pharma
— Bill Farley | Vice President, Business and Corporate Development, Sorrento Therapeutics
|2.55 pm||Wrap up and end of symposia|